Saroja Pharma Industries India Limited IPO Detail
Incorporated in 2019, Saroja Pharma Industries India Limited is engaged in trading, exporting and supplying Specialty Chemicals & API.
The company deals in three types of product categories:
1. Chemical, 2. Pharma Intermediary and 3. Veterinary Pharma API. The company supplies products such as Liquide Bromine, which is used as an agro-intermediate, Ethyl Acetate, which is used as an API solvent, and other pharmaceuticals used for human and veterinary drugs, and some of them are API solvents.
APIs, known as bulk drugs or bulk actives, are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid or other forms of dosage, with the addition of other APIs or inactive ingredients.
The company exports products mainly in Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore etc.
Competitive Strength:
- Experienced Promoters and Management Team
- Scalable Business Model
- Wide and diverse range of product offerings
- Diversified business operations and revenue base
Company Promoters
Mr. Biju Gopinathan Nair and Mr. Manish Dasharath KambleIPO Details
| IPO Opening Date | Aug 31, 2023 |
| IPO Closing Date | Sep 05, 2023 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹84 per equity share |
| Market Lot | 1600 Shares |
| Min Order Quantity | 1600 Shares |
| Listing At | NSE SME |
| Issue Size | ₹9.11 Cr |
| Fresh Issue | ₹9.11 Cr |
| Offer for Sale | - |
| Retail Portion | 50% |
IPO Tentative Timetable
The Saroja Pharma Industries India Limited IPO open date is Aug 31, 2023, and the close date is Sep 05, 2023. The issue may list on Sep 13, 2023.
| IPO Open Date | Aug 31, 2023 |
| IPO Close Date | Sep 05, 2023 |
| Basis of Allotment Date | Sep 08, 2023 |
| Initiation of Refunds | Sep 11, 2023 |
| Credit of Shares to Demat Account | Sep 12, 2023 |
| IPO Listing Date | Sep 13, 2023 |
IPO Lot Size
The Saroja Pharma Industries India Limited IPO market lot size is 1600 shares. A retail-individual investor can apply for up to 1 lots (1600 shares or ₹134400).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 1600 | ₹134400 |
| Maximum | 1 | 1600 | ₹134400 |
IPO Promoter Holding
| Pre Issue Share Holding | 100.00% |
| Post Issue Share Holding | 73.02% |
Company Financials:
For the year/period ended (₹ in Lakhs)
| Financial Year | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 822.39 | 3674.67 | 73.13 |
| 31-Mar-22 | 1551.19 | 5595.67 | 114.01 |
| 31-Mar-23 | 2133.99 | 5035.09 | 106.06 |
Objects of the Issue:
The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:
1. To Set-up a Manufacturing Unit.
2. To Repay the Unsecured Loans.
3. Public Issue Expenses.
Saroja Pharma Industries India Limited IPO Registrar:
KFin Technologies Limited
Saroja Pharma Industries India Limited IPO Lead Manager(s):
Swastika Investmart Ltd
Company Contact Information:
Saroja Pharma Industries India Limited
305, Kailash Tower, Shiv Shristi Complex,
Goregaon Link Road, Mulund West,
Mumbai (MH) – 400080
